Dengue Fever News and Research

RSS

Dengue fever is a mosquito-borne tropical disease caused by the dengue virus. Symptoms typically begin three to fourteen days after infection. These may include a high fever, headache, vomiting, muscle and joint pains, and a characteristic skin rash.

Urban mosquito control with help from scientists

Thanks to an innovative mosquito control approach developed at Rutgers University-New Brunswick, residents in several Maryland neighborhoods reduced populations of invasive Asian tiger mosquitoes by an impressive 76 percent, on average.

25 Oct 2018

Emergex completes toxicology testing on gold nanoparticle carrier system for vaccine platform

Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to synthetic vaccine development in the field of infectious diseases, today announces the successful completion of preclinical toxicology testing on the gold nanoparticle carrier system that forms the fundamental basis for Emergex's entire infectious disease vaccine platform.

24 Oct 2018

A new approach identified to control Zika virus, dengue fever

Mosquitoes are the world's deadliest animals, killing thousands of people and causing millions of illnesses each year.

19 Oct 2018

Special glowing paper strip as rapid, reliable test for infectious diseases

Researchers from Eindhoven University of Technology (The Netherlands) and Keio University (Japan) present a practicable and reliable way to test for infectious diseases.

3 Oct 2018

Emergex signs MoU with Brazil’s Fiocruz for development of viral vaccines

Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to synthetic vaccine development in the field of infectious diseases, today announces that it has signed a Memorandum of Understanding with Brazil-based Oswaldo Cruz Foundation 'Fiocruz' for the development of viral vaccines.

20 Sep 2018

Researchers use CRISPR to identify gene that helps cells resist flavivirus infection

UT Southwestern researchers today report the first use of CRISPR genome-wide screening to identify a gene that helps cells resist flavivirus infection. That nasty class of pathogens includes West Nile virus, dengue fever, Zika virus, and yellow fever.

18 Sep 2018

New class of insect repellents to fight against mosquito-borne diseases

Nearly 700 million people suffer from mosquito-borne diseases - such as malaria, West Nile, Zika and dengue fever - each year, resulting in more than 1 million deaths. Increasingly, many species of mosquitoes have become resistant to the popular pyrethroid-based insecticides.

20 Aug 2018

Female mosquitoes quickly evolve selective mating behavior when faced with threats

Certain female mosquitoes quickly evolve more selective mating behavior when faced with existential threats from other invasive mosquito species, with concurrent changes to certain genetic regions, according to new research from North Carolina State University.

17 Aug 2018

Unique experimental vaccine against Zika virus proves powerful in mice

A uniquely designed experimental vaccine against Zika virus has proven powerful in mice, new research has found.

6 Aug 2018

NIH researchers identify natural lipid that acts as potent anti-inflammatory

National Institutes of Health researchers have identified a naturally occurring lipid--a waxy, fatty acid--used by a disease-causing bacterium to impair the host immune response and increase the chance of infection. Inadvertently, they also may have found a potent inflammation therapy against bacterial and viral diseases.

9 Jul 2018

Study reveals new way to inhibit capillary leakage in sepsis

Leakage from the blood capillaries is a key mechanism leading to septic shock and multiorgan failure, which affect millions of patients annually worldwide. However, there is no effective way to inhibit the vessel leakiness. A new study by scientists at the University of Helsinki and Wihuri Research Institute demonstrates that vascular leakage can be inhibited by targeting vascular integrins.

25 Jun 2018

Limiting global warming could reduce millions of dengue cases every year

Limiting global warming to 1.5°C could avoid around 3.3 million cases of dengue fever per year in Latin America and the Caribbean alone - according to new research from the University of East Anglia.

28 May 2018

Study: People showing no symptoms likely to be primary source of dengue fever

People showing virtually no symptoms are likely the primary source of dengue fever, according to new research published in PLOS Pathogens. Nearly 400 million people each year are infected with dengue virus, which is transmitted through mosquitoes.

4 May 2018

Climate change spurs proliferation of disease-bearing insects, increases exposure to viral infections

Scientists at the Joint Research Centre, the European Commission's science and knowledge service, find that global warming has allowed disease-bearing insects to proliferate, increasing exposure to viral infections.

16 Mar 2018

Lassa fever strikes in Nigeria - high rates of fatality with no cure and no vaccine

Nigeria has been affected with an outbreak of the deadly Lassa fever since the start of this year. This disease typically has a high rate of fatality, no known cure and no vaccines have been developed against it yet. This is an unprecedented outbreak of this disease that is spreading faster than before. It is infecting more individuals than health workers can handle with their limited resources, say official sources.

5 Mar 2018

Scientists evaluate reliability of Zika virus diagnostics

Globally, Brazil has been the hardest hit by the current Zika outbreak. Almost all cases of Zika-associated malformations in newborns have been reported from this country

2 Mar 2018

BGN Technologies collaborates with Biosensorix to develop new cost-effective diagnostic kit

BGN Technologies, the technology transfer company of Ben-Gurion University of the Negev, announced today its collaboration with Biosensorix, a Singapore-based company in the field of medical diagnostics, to develop next-generation, quantitative, point-of-care diagnostics based on research conducted at Ben-Gurion University.

27 Feb 2018